SPTBN1 and cancer, which links?

Shuyi Chen1, Jiajia Li2, Ping Zhou1

  • 1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Insights

The spectrin beta-1 (SPTBN1) protein plays a role in transforming growth factor-β signaling and cancer development. Understanding SPTBN1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Spectrin beta-1 (SPTBN1) is an intracellular protein involved in transforming growth factor-β (TGF-β) signaling.
  • SPTBN1 facilitates the formation of the Smad3/Smad4 complex, a key component in TGF-β pathways.
  • Emerging evidence links SPTBN1 to various cancer types, with expression varying across different tumor states.

Purpose of the Study:

  • To review recent findings on SPTBN1 expression patterns in cancers.
  • To elucidate the mechanisms underlying SPTBN1's influence on cancer occurrence, progression, and metastasis.
  • To highlight the potential of SPTBN1 as a biomarker and therapeutic target in oncology.

Main Methods:

  • Literature review of studies investigating SPTBN1 in cancer.
  • Analysis of SPTBN1 expression data across different cancer types.
  • Examination of experimental evidence on SPTBN1's functional roles in cancer biology.

Main Results:

  • SPTBN1 expression levels and functions are notably altered in various cancers.
  • SPTBN1 participates in critical cellular processes relevant to tumorigenesis and cancer spread.
  • Specific mechanisms of SPTBN1 action in cancer are being uncovered, linking it to signal transduction pathways.

Conclusions:

  • SPTBN1 is implicated in the development and progression of multiple cancers.
  • Further research into SPTBN1's role can inform clinical cancer diagnosis and treatment strategies.
  • Targeting SPTBN1 may offer new avenues for anticancer drug development.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.8K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

2.0K
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
58.3K
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
108.5K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.3K
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
17.4K